Tag: mitochondrial medicine

November 8, 2016

NeuroVive Recruits Michele Tavecchio as Senior Scientist

NeuroVive Pharmaceutical, the mitochondrial medicine company, today announced that the company has recruited Michele Tavecchio, PhD, as senior scientist.
November 1, 2016

NeuroVive Reports Positive Pre-Clinical Results in NASH

NeuroVive Pharmaceutical today announced positive pre-clinical results with one of its cyclophilin inhibitors, NVP018, in an experimental model of the...
October 21, 2016

NeuroVive and Arbutus Sign Termination Agreement

NeuroVive Pharmaceutical, the mitochondrial medicine company, today announces that the license agreement with Arbutus Biopharma (formerly OnCore Biopharma, Inc.) has...
October 13, 2016

NeuroVive Discontinues Development of CicloMulsion for Acute Kidney Injury

NeuroVive Pharmaceutical, the mitochondrial medicine company, today announced results from the exploratory clinical phase II study CiPRICS.